Picard Medical, Inc. (PMI) stock
PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3076% above fair value
$6.91−0.33 (-4.56%)
Close on Nov 17, 2026Market cap $16.16MP/E –Yield –
Picard Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Picard Medical's profit margin for the twelve months ending Sep 30, 2026 was -371.2%. For fiscal 2025 it was -546.6%, against -479.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -546.6% | −67.1 |
| FY2024 | Dec 31, 2024 | -479.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1022.6% | −144.2 |
| Q2 FY2026 | Jun 30, 2026 | -191.6% | +123.9 |
| Q1 FY2026 | Mar 31, 2026 | -662.3% | +234.7 |
| Q4 FY2025 | Dec 31, 2025 | -425.3% | +631.9 |
| Q3 FY2025 | Sep 30, 2025 | -878.3% | −173.9 |
| Q2 FY2025 | Jun 30, 2025 | -315.5% | +269.0 |
| Q1 FY2025 | Mar 31, 2025 | -896.9% | – |
| Q4 FY2024 | Dec 31, 2024 | -1057.2% | – |
| Q3 FY2024 | Sep 30, 2024 | -704.4% | – |
| Q2 FY2024 | Jun 30, 2024 | -584.6% | – |
See a number that looks wrong?